Account
Inquiry
QSC Tirzepatide is a synthetic peptide compound with dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist activity. This innovative peptide has shown significant potential in metabolic research applications.
The qsc tirzepatide compound works through multiple mechanisms to support metabolic research: slowing gastric emptying, increasing satiety signals, and improving glycemic control. Researchers have documented its effects on weight management and glucose metabolism in preclinical studies.
Key characteristics of our qsc tirzepatide include: 99% purity by HPLC analysis, lyophilized white powder form, and pharmaceutical grade quality. The peptide is supplied in sterile vials with rubber stoppers for research convenience.
Storage recommendations: Maintain qsc tirzepatide at 2-8°C in dry conditions. Avoid repeated freeze-thaw cycles and protect from light exposure to preserve stability. For research use only - not for human consumption.
